Development and maturation of secondary lymphoid tissues

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 399-433

  Fu, Yang Xin ^a,b   Chaplin, David D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Follicular dendritic cells; Lymph node; Lymphotoxin; Peyer's patch; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; IMMUNE SYSTEM; LYMPHOID TISSUE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; GTP-BINDING PROTEINS; HUMANS; IKAROS TRANSCRIPTION FACTOR; LYMPH NODES; LYMPHOID TISSUE; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PEYER'S PATCHES; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPLEEN; TRANSCRIPTION FACTORS;

EID: 0033006011     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.399     Document Type: Review

References (120)

1. Goodnow CC. 1997. Chance encounters and organized rendezvous. Immunol. Rev. 156:5-10
2. MacLennan IC, Gulbranson-Judge A, Toellner KM, Casamayor-Palleja M, Chan E, Sze DM, Luther SA, Orbea HA. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53-66
3. Steinman RM, Pack M, Inaba K. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25-37
4. Castenholz A. 1990. Architecture of the lymph node with regard to its function. Curr. Top. Pathol. 84:1-32
5. Witmer MD, Steinman RM. 1984. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am. J. Anat. 170:465-81
6. Timens W. 1991. The human spleen and the immune system: not just another lymphoid organ. Res. Immunol. 142:316-20
7. Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H, Gessner A, Kuhlcke K, Ohashi PS, Hengartner H, Zinkernagel RM. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268:1343-47
8. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. 1997. Antigen localisation regulates immune responses in a dose- and time-dependent fashion - a geographical view of immune reactivity. Immunol. Rev. 156:199-209
9. Burton GF, Conrad DH, Szakal AK, Tew JG. 1993. Follicular dendritic cells and B cell costimulation. J. Immunol. 150:31-38
10. Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Shultz LD, Tew JG, Szakal AK. 1998. Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. J. Immunol. 160:1078-84
11. Liu Y-J, Xu J, de Bouteiller O, Parham CL, Grouard G, Djossou O, de Saint-Vis B, Lebecque S, Banchereau J, Moore KW. 1997. Follicular dendritic cells specifically express the long CR2/ CD21 isoform. J. Exp. Med. 185:165-70
12. Tew JG, Wu JH, Qin DH, Helm S, Burton GF, Szakal AK. 1997. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol. Rev. 156:39-52
13. Gretz JE, Anderson AO, Shaw S. 1997. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156:11-24
14. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
15. Kuper CF, Koornstra PJ, Hameleers DM, Biewenga J, Spit BJ, Duijvestijn AM, van Breda Vriesman PJ, Sminia T. 1992. The role of nasopharyngeal lymphoid tissue. Immunol Today 13:219-24
16. Sminia T, van der Brugge-Gamelkoorn GJ, Jeurissen SH. 1989. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit. Rev. Immunol. 9:119-50
17. Neutra MR, Krachenbuhl JP. 1992. M cell-mediated antigen transport and monoclonal IgA antibodies for mucosal immune protection. Adv. Exp. Med. Biol. 327:143-50
18. Brown AR. 1992. Immunological functions of splenic B lymphocytes. Crit. Rev. Immunol. 11:395-417
19. Yamauchi H. 1968. Estimation of blood flow in the Banti spleen on anatomical basis. Tohoku. J. Exp. Med. 95:63-77
20. Kraal G, Schornagel K, Streeter PR, Holzmann B, Butcher EC. 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 147:763-71
21. Kraal G, Janse M. 1986. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58:665-69
22. Chaplin DD, Fu Y-X. 1998. Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 10:289-97
23. van Krieken JH, von Schilling C, Kluin PM, Lennert K. 1989. Splenic marginal zone lymphocytes and related cells in the lymph node: a morphologic and immunohistochemical study. Hum. Pathol. 20:320-25
24. Oldfield S, Liu YJ, Beaman M, MacLennan CM. 1988. Memory B cells generated in T cell-dependent antibody responses colonise the splenic marginal zone. Adv. Exp. Med. Biol. 237:93-98
25. MacLennan IC. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-39
26. Karrer Y, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, Miyawaki S, Hengartner H, Zinkernagel RM. 1997. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (hox11(-/-)) mutant mice. J. Exp. Med. 185:2157-70
27. Flanagan SP. 1966. 'Nude,' a new hairless gene with pleoptropic effects in the mouse. Genet. Res. 8:295-309
28. Ware CF, VanArsdale TL, Crowe PD, Browning JL. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175-218
29. Nehls M, Kyewski B, Messerle M, Waldschulz R, Schuddekopf K, Smith AJH, Boehm T. 1996. Two genetically separable steps in thu differentiation of thymic epithelium. Science 272:886-89
30. Schuddekopf K, Schorpp M, Boehm T. 1996. The whn transcription factor encoded by the nude locus contains an evolutionarily conserved and functionally indispensable activation domain. Proc. Natl. Acad. Sci. USA 93:9661-64
31. Schlake T, Schorpp M, Nehls M, Boehm T. 1997. The nude gene encodes a sequence-specific DNA binding protein with homologs in organisms that lack an anticipatory immune system. Proc. Natl. Acad. Sci. USA 94:3842-47
32. Searle AG. 1964. The genetics and morphology of two "luxoid" mutants in the house mouse. Genet. Res. 5:171-97
33. Suto J, Wakayama T, Imamura K, Goto S, Fukuta K. 1995. Incomplete development of the spleen and the deformity in the chimeras between asplenic mutant (Dominant hemimelia) and normal mice. Teratology 52:71-77
34. Miyawaki S, Nakamura Y, Suzuka H, Koba M, Yasumizu R, Ikehara S, Shihata Y. 1994. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:429-34
35. Shinkura R, Matsuda F, Sakiyama T, Tsubata T, Hiai H, Paumen M, Miyawaki S, Honjo T. 1996. Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice. Int. Immunol. 8:1067-75
36. Adachi S, Yoshida H, Kataoka H, Nishikawa S. 1997. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9:507-14
37. Roberts CW, Shutter JR, Korsmeyer SJ. 1994. Hox11 controls the genesis of the spleen. Nature 368:747-49
38. Roberts CW, Sonder AM, Lumsden A, Korsmeyer SJ. 1995. Development expression of Hox11 and specification of splenic cell fate. Am. J. Pathol. 146:1089-101
39. Ruddle NH. 1992. Tumor necrosis factor (TNF-α) and lymphotoxin (TNFβ). Curr. Opin. Immunol. 4:327-32
40. Kriegler M, Perez C, DeFay K, Albert I, Lu SD. 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53
41. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Stack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Parton RJ, March CJ, Cerretti DP. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729-33
42. Moss ML, Jin S-LC, Milla ME, Burkhart W, Carter HL, Chen W-J, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su J-L, Warner J, Willard D, Becherer JD. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-36
43. Browning JL, Androlewicz MJ, Ware CF. 1991. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J. Immunol. 147:1230-37
44. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF. 1993. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-56
45. Browning JL, Dougas I, Ngam-ek A, Bourdon PR, Ehrenfels BN, Miatkowski K, Zafari M, Yampaglia AM, Lawton P, Meier W, Benjamin CP, Hession C. 1995. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33-16
46. Lawton P, Nelson J, Tizard R, Browing JL. 1995. Characterization of the mouse lymphotoxin-β gene. J. Immunol. 154:239-46
47. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA. 1994. A lymphotoxin-β-specific receptor. Science 264:707-10
48. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr RW, Chaplin DD. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-7
49. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML. 1995. Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685-93
50. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-25
51. Fu Y-X, Huang G, Matsumoto M, Molina H, Chaplin DD. 1997. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl. Acad. Sci. USA 94:5739-43
52. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-67
53. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KCF, Schreiber RD, Goeddel DV, Moore MW. 1994. Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-63
54. Mariathasan S, Matsumoto M, Baranyay F, Nahm MH, Kanagawa O, Chaplin DD. 1995. Absence of lymph nodes in lymphotoxin-α (LTα)-deficient mice is due to abnormal organ development, not defective lymphocyte migration. J. Inflamm. 45:72-78
55. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. 1996. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999-2006
56. Rennert PD, Browning JL, Hochman PS. 1997. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int. Immunol. 9:1627-39
57. Ettinger R, Browning JL, Michie SA, van Ewijk W, McDevitt HO. 1996. Disrupted splenic architecture, hut normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci. USA 93:13102-7
58. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6:491-500
59. Koni PA, Flavell RA. 1998. A role for tumor necrosis factor receptor type I in gut-associated lymphoid tissue development - genetic evidence of synergism with lymphotoxin β. J. Exp. Med. 187: 1977-83
60. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. 1998. Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity 9:71-79
61. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. 1998. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymhoid tissues. Immunity 9:59-70
62. Neumann B, Luz A, Pfeffer K, Holzmann B. 1996. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 184:259-64
63. Pasparakis M, Alexopoulou L, Grell M, Pfizenmaier K, Blucthmann H, Kollias G. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94:6319-23
64. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:10.17-47
65. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitts-lymphoma receptor-1. Nature 391:799-803
66. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. 1998. B cell-attracting chemokine I, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:655-60
67. Georgopoulos K, Winandy S, Avitahl N. 1997. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15:155-76
68. Sun L, Liu A, Georgopoulos K. 1996. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15:5358-69
69. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537-49
70. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. 1997. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7:483-92
71. Leonard WJ, Shores EW, Love PE. 1995. Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97-114
72. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-38
73. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migonc T-S, Noguchi M, Markert ML, Buckley RH, O'Shea JJ, Leonard WJ. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800
74. Nosaka T, van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN. 1995. Defective lymphoid development in mice lacking Jak3. Science 270:800-2
75. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794-97
76. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T, Saito T. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771-82
77. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271:1289-91
78. Matsumoto M, Lo SF, Carruthers CJL, Min J, Mariathasan S, Huang G, Plas DR, Martin SM, Geha RS, Nahm Mil, Chaplin DD. 1996. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 382:462-66
79. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL, Tarakhovsky A, Rajewsky K, Nedospasov SA, Pfeffer K. 1997. Abnormal development of secondary lymphoid tissues in lymphotoxin-β-deficient mice. Proc. Natl. Acad. Sci. USA 94:9302-7
80. Fu Y-X, Molina H, Matsumoto M, Huang G, Min J, Chaplin DD. 1997. Lymphotoxin-α supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:2111-20
81. Alexopoulou L, Pasparakis M, Kollias G. 1998. Complementation of lymphotoxin-α knockout mice with tumor necrosis factor-expressing transgcnes rectifies defective splenic structure and function. J. Exp. Med. 188:745-54
82. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. 1996. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl. Acad. Sci. USA 93:13090-95
83. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. 1996. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks, and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-411
84. Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ. 1998. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187:997-1007
85. Muller M, Eugster H-P, Le Hir M, Shakhov A, di Padova F, Maurer C, Quesniaux VFJ, Ryffel B. 1996. Correction or transfer of immunodeficiency due to TNF-LTα deletion by bone marrow transplantation. Mol. Med. 2:247-55
86. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033-42
87. Le Hir M, Bleuthmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, Ryffel B, Eugster H-P. 1996. Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses. J. Inflamm. 47:76-80
88. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Kontgen F, Fazekas de St Groth B, Sedgewick JD. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600-9
89. Murphy M, Pike-Nobile L, Browning JL, Ware CF, Epstein LB. 1995. Expression of lymphotoxin-β receptor in human thymus and spleen. Proc. 9th Int. Congr. Immunol., p. 770 (Abstr.)
90. Ryffel B, Mihatsch MJ. 1993. TNF receptor distribution in human tissues. Int. Rev. Exp. Pathol. 34B:149-56
91. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-98
92. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802
93. Paul NL, Ruddle NH. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407-38
94. Fu Y-X, Huang GM, Wang Y, Chaplin DD. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin-α-dependent fashion. J. Exp. Med. 187:1009-18
95. Wang B, Hollander GA, Nichogiannopoulou A, Simpson SJ, Orange JS, Gutierrez-Ramos JC, Burakoff SJ, Biron CA, Terhorst C. 1996. Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny. Int. Immunol. 8:939-49
96. Mandel TE, Phipps RP, Abbot A, Tew JG. 1980. The follicular dendritic cell: long tenu antigen retention during immunity. Immunol. Rev. 53:29-59
97. Cerny A, Zinkernagel RM, Groscurth P. 1988. Development of follicular dendritic cells in lymph nodes of B-cell-depleted mice. Cell Tissue Res. 254:449-54
98. Kapasi ZF, Burton GF, Shultz LD, Tew JG, Szakal AK. 1993. Induction of functional follicular dendritic cell development in severe combined immunodeficiency mice. Influence of B and T cells. J. Immunol. 150:2648-58
99. Yoshida K, van den Berg TK, Dijkstra CD. 1994. The functional state of follicular dendritic cells in severe combined immunodeficient (SCID) mice: role of the lymphocytes. Eur. J. Immunol. 24:464-68
100. Imai Y, Yamakawa M. 1996. Morphology, function and pathology of follicular dendritic cells. Pathol. Int. 46:807-33
101. Matsumoto M, Fu Y-X, Molina H, Huang G, Kim J, Thomas D, Nahm MH, Chaplin DD. 1997. Distinct roles of lymphotoxin-α and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from nonbone marrow-derived cells. J. Exp. Med. 186:1997-2004
102. Liu YJ, Arpin C. 1997. Germinal center development. Immunol. Rev. 156:111-26
103. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-63
104. Sato S, Steeber DA, Jansen PJ, Tedder TF. 1997. CD19 expression levels regulate B lymphocyte development. Human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158:4662-69
105. Ferguson SE, Han S, Kelsoe G, Thompson CB. 1996. CD28 is required for germinal center formation. J. Immunol. 156:4576-81
106. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacohy D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303-13
107. Weih F, Warr G, Yang H, Bravo R. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211-18
108. Franzoso G, Carlson L, Poljack L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Schartonkersten T, Anver M, Love P, Brown K, Siebenlist U. 1998. Mice deficient in nuclear factor (NF)-kappa-B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147-59
109. Schwarz EM, Krimpenfort P, Berns A, Verma IM. 1997. Immunological defects in mice with a targeted disruption of Bcl-3. Genes Dev. 11:187-97
110. Franzoso G, Carlson L, Schartonkersten T, Shores EW, Epstein S, Grinberg A, Tran T, Shacter E, Leonardi A, Anver M, Love P, Sher A, Siebenlist U. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6:479-90
111. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-92
112. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N, Tokuhisa T. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186:439-48
113. Molina H, Holers VM, Li B, Fang Y-F, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357-61
114. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493-504
115. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183:1461-72
116. Sacca R, Turley S, Soong L, Mellman I, Ruddle NH. 1997. Transgenic expression of lymphotoxin restores lymph nodes to lymphotoxin-α-deficient mice. J. Immunol. 159:4252-60
117. Villavedra M, Carol H, Hjulstrom M, Holmgren J, Czerkinsky C. 1997. "PERFEXT": a direct method for quantitative assessment of cytokine production in vivo at the local level. Res. Immunol. 148:257-66
118. Forsthuber T, Yip HC, Lehmann PV. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728-30
119. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung G-L, Yu TC, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8:21-30
120. Annu. Rev. Immunol. 1999. 17:435-66